CE4 Cost-Effectiveness of Dabigatran Compared to Genotype-Guided Warfarin Dosing for Stroke Prophylaxis in Atrial Fibrillation Patients

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.006
https://www.valueinhealthjournal.com/article/S1098-3015(12)01719-6/fulltext
Title : CE4 Cost-Effectiveness of Dabigatran Compared to Genotype-Guided Warfarin Dosing for Stroke Prophylaxis in Atrial Fibrillation Patients
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01719-6&doi=10.1016/j.jval.2012.08.006
First page : A602
Section Title : Cost-Effectiveness Studies
Open access? : No
Section Order : 1570
Categories :
Tags :
Regions :
ViH Article Tags :